Padmanabh Healthcare Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.50 Cr
as on 16-11-2024
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.86 Cr
as on 16-11-2024
- Satisfied Charges ₹ 117.61 Cr
as on 16-11-2024
- Revenue 2.87%
(FY 2023)
- Profit -27.69%
(FY 2023)
- Ebitda 2.44%
(FY 2023)
- Net Worth 69.14%
(FY 2023)
- Total Assets 5.56%
(FY 2023)
About Padmanabh Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 3.50 Cr.
The company currently has active open charges totaling ₹18.86 Cr. The company has closed loans amounting to ₹117.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kamal Garg, Seema Avtar, and Krishan Avtar serve as directors at the Company.
- CIN/LLPIN
U74900DL2009PTC191259
- Company No.
191259
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Padmanabh Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamal Garg  | Director | 16-Jun-2009 | Current |
| Seema Avtar | Director | 16-Jun-2009 | Current |
| Krishan Avtar | Director | 11-Feb-2010 | Current |
Financial Performance of Padmanabh Healthcare.
Padmanabh Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.87% increase. The company also saw a substantial fall in profitability, with a 27.69% decrease in profit. The company's net worth Soared by an impressive increase of 69.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Padmanabh Healthcare?
In 2023, Padmanabh Healthcare had a promoter holding of 97.00% and a public holding of 3.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 May 2024 | ₹18.86 Cr | Open |
Axis Bank Limited Creation Date: 30 Oct 2021 | ₹3.00 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 02 Aug 2021 | ₹32.50 Cr | Satisfied |
How Many Employees Work at Padmanabh Healthcare?
Unlock and access historical data on people associated with Padmanabh Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Padmanabh Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Padmanabh Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
